| Name | Title | Contact Details |
|---|
CDW (Nasdaq:CDW) is a leading multi-brand technology solutions provider to business, government, education and healthcare organizations in the United States, the United Kingdom and Canada. A Fortune 500 company and member of the S&P 500 Index, CDW features dedicated account managers who help customers choose the right technology products and services to meet their needs. The company`s solution architects offer expertise in designing customized solutions, while its advanced technology engineers assist customers with the implementation and long-term management of those solutions. Areas of focus include software, network communications, notebooks/mobile devices, data storage, video monitors, desktops, printers and solutions such as virtualization, collaboration, security, mobility, data center optimization and cloud computing. CDW was founded in 1984 and employs almost 10,000 coworkers. For the year ended December 31, 2019, the company generated net sales over $18 billion.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
Concensus Consulting, LLC is a Cranberry Twp, PA-based company in the Computers and Electronics sector.
ATX Networks is disrupting broadband access with the world’s most innovative cable, satellite, fixed telecom, wireless and audio broadcast solutions.
ProfitOptics solves unsolvable tech challenges by combining custom software and data solutions to empower clients to do the impossible. Companies work with us to leave behind cumbersome software, outdated systems, and the competition. We combine tailored tech and next-generation data solutions to create proprietary intelligence and exponential value. → Over $2B in positive financial impact on its clients` bottom lines → 99% client satisfaction → 90+% client annual renewal rate → Inc. 5000 fastest-growing company for nine years in a row